Lifecore Biomedical, Inc.
LFCR
$7.90
$0.070.89%
NASDAQ
| 09/30/2025 | 05/25/2025 | 02/23/2025 | 11/24/2024 | 08/25/2024 | |
|---|---|---|---|---|---|
| Revenue | 135.27M | 128.87M | 130.31M | 130.86M | 128.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 135.27M | 128.87M | 130.31M | 130.86M | 128.45M |
| Cost of Revenue | 92.57M | 88.57M | 86.72M | 85.22M | 83.94M |
| Gross Profit | 42.70M | 40.30M | 43.59M | 45.64M | 44.51M |
| SG&A Expenses | 38.68M | 42.07M | 45.32M | 45.07M | 43.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 139.29M | 138.90M | 140.36M | 138.74M | 136.09M |
| Operating Income | -4.02M | -10.03M | -10.05M | -7.88M | -7.65M |
| Income Before Tax | -32.08M | -38.67M | -44.70M | -14.92M | 5.78M |
| Income Tax Expenses | 401.00K | 43.00K | -47.00K | 178.00K | 70.00K |
| Earnings from Continuing Operations | -32.48 | -38.72 | -44.66 | -15.10 | 5.71 |
| Earnings from Discontinued Operations | -- | -- | 3.00K | 850.00K | 826.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -32.48M | -38.72M | -44.65M | -14.25M | 6.54M |
| EBIT | -4.02M | -10.03M | -10.05M | -7.88M | -7.65M |
| EBITDA | 4.00M | -2.01M | -1.92M | 179.00K | 130.00K |
| EPS Basic | -1.07 | -1.30 | -1.48 | -0.50 | 0.22 |
| Normalized Basic EPS | -0.47 | -0.59 | -0.66 | -0.20 | 0.21 |
| EPS Diluted | -1.07 | -1.31 | -1.49 | -0.59 | 0.05 |
| Normalized Diluted EPS | -0.47 | -0.59 | -0.66 | -0.25 | 0.11 |
| Average Basic Shares Outstanding | 145.79M | 139.24M | 132.79M | 126.25M | 122.35M |
| Average Diluted Shares Outstanding | 145.79M | 139.24M | 132.79M | 132.37M | 134.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |